Our client requested us to secure large quantities of a high, in-demand oncology product in both strengths that the product is available.
The client wanted CSI to deliver samples to perform specific analytical testing; once the testing was performed and the results were satisfactory, the client requested CSI to deliver the stock of the same batches with all documentation available for exports.
There are several challenges here: first, stock availability. Due to our in-depth knowledge of the market, we only targeted specific countries.
Second challenge: the ability to supply a specific batch.
We leveraged our outstanding relationships with authorised wholesalers to hold a stock of this expensive drug while the testing was being carried out. CSI would purchase following confirmation from the client of satisfactory analytical testing or ask the supplier to rotate stock and try again with the next batch in case the analytical test was not satisfactory.
We delivered above expectations and our client could meet corporate objectives.
I am truly extremely pleased that CSI managed to achieve the purchasing and delivery milestones which one could say “Mission Impossible” considering the tight market situation and strict requirement to test a batch which lead to the needs to reserve stock for weeks. A very BIG THANK YOU to CSI team for going beyond. Without you, we would be at a loss and not able to achieve the FPI milestone.
Top 5 CRO.